A study to look at how safe was it to give people with blood cancer (non-Hodgkin’s lymphoma and chronic lymphocytic leukemia) – different doses of a study medicine (fenebrutinib)
-
Cancer -
Non Hodgkin Lymphoma (NHL) -
Diffuse Large B-Cell Lymphoma (DLBCL) -
Leukemia -
Chronic Lymphocytic Leukemia
For the latest version of this information please go to www.forpatients.roche.com